Furthermore, Western blot analysis demonstrated a significant reduction in the levels of ECM proteins, including COL1α1, FN1, ELN, and α smooth muscle actin (αSMA), in IPF fibroblasts treated with WT1-specific siRNA compared with control siRNA (Figure 4, E–I). The gene discussed is WT1; the disease is idiopathic pulmonary fibrosis.